ANDROGEN-INDUCED REMISSIONS AFTER ANTI-ESTROGEN AND HYPOPHYSECTOMY IN STAGE-IV BREAST-CANCER

被引：0
|
作者：
MANNI, A [1 ]
ARAFAH, B [1 ]
PEARSON, OH [1 ]
机构：
[1] CASE WESTERN RESERVE UNIV,DEPT MED,CLEVELAND,OH 44106
来源：
CLINICAL RESEARCH | 1980年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A418 / A418
页数：1
相关论文
共 50 条
  • [21] Pathologic Changes in Breast Cancer After Anti-Estrogen Therapy
    Samarnthai, Norasate
    Elledge, Richard
    Prihoda, Thomas J.
    Huang, Jian
    Massarweh, Suleiman
    Yeh, I-Tien
    BREAST JOURNAL, 2012, 18 (04): : 362 - 366
  • [22] Pathologic changes in breast cancer after anti-estrogen therapy
    Samarnthai, Norasate
    Elledge, Richard
    Huang, Jian
    Massarweh, Suleiman
    Yeh, I-Tien
    FASEB JOURNAL, 2010, 24
  • [23] BENIGN HEPATIC CYST IN A PATIENT ON ANTI-ESTROGEN THERAPY FOR METASTATIC BREAST-CANCER
    NAND, S
    GORDON, LI
    BRESTAN, E
    HARRIS, C
    BRANDT, T
    CANCER, 1982, 50 (09) : 1882 - 1883
  • [24] A RANDOMIZED TRIAL COMPARING MITOXANTRONE WITH DOXORUBICIN IN PATIENTS WITH STAGE-IV BREAST-CANCER
    ALLEGRA, JC
    WOODCOCK, T
    WOOLF, S
    HENDERSON, IC
    BRYAN, S
    REISMAN, A
    DUKART, G
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (02) : 153 - 161
  • [25] UPDATE ON THE ADJUVANT CHEMO-IMMUNOTHERAPY OF STAGE-IV NED BREAST-CANCER
    BLUMENSCHEIN, GR
    BUZDAR, AU
    HORTOBAGYI, GN
    TASHIMA, CK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 368 - 368
  • [26] Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
    Bronte, Giuseppe
    Rocca, Andrea
    Ravaioli, Sara
    Puccetti, Maurizio
    Tumedei, Maria Maddalena
    Scarpi, Emanuela
    Andreis, Daniele
    Maltoni, Roberta
    Sarti, Samanta
    Cecconetto, Lorenzo
    Pietri, Elisabetta
    De Simone, Valeria
    Asioli, Silvia
    Amadori, Dino
    Bravaccini, Sara
    BMC CANCER, 2018, 18
  • [27] Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
    Giuseppe Bronte
    Andrea Rocca
    Sara Ravaioli
    Maurizio Puccetti
    Maria Maddalena Tumedei
    Emanuela Scarpi
    Daniele Andreis
    Roberta Maltoni
    Samanta Sarti
    Lorenzo Cecconetto
    Anna Fedeli
    Elisabetta Pietri
    Valeria De Simone
    Silvia Asioli
    Dino Amadori
    Sara Bravaccini
    BMC Cancer, 18
  • [28] Is androgen receptor useful to predict the efficacy of anti-estrogen therapy in advanced breast cancer?
    Rocca, Andrea
    Bronte, Giuseppe
    Ravaioli, Sara
    Puccetti, Maurizio
    Tumedei, Maria Maddalena
    Scarpi, Emanuela
    Maltoni, Roberta
    Sarti, Samanta
    Cecconetto, Lorenzo
    Bedei, Lucia
    Fedeli, Anna
    Andreis, Daniele
    Pietri, Elisabetta
    Calistri, Daniele
    Amadori, Dino
    Bravaccini, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] SERUM FERRITIN AS A MARKER OF THERAPEUTIC RESPONSE IN STAGE-III AND STAGE-IV BREAST-CANCER
    WILLIAMS, MR
    TURKES, A
    PEARSON, D
    GRIFFITHS, K
    BLAMEY, RW
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1990, 16 (01): : 22 - 27
  • [30] MECHANISMS OF ESTROGEN AND ANTI-ESTROGEN ACTION IN HUMAN BREAST-CANCER - ROLE OF NUCLEAR PROCESSING OF ESTROGEN-RECEPTOR
    HORWITZ, KB
    MCGUIRE, WL
    CLINICAL RESEARCH, 1978, 26 (03): : A492 - A492
12345